KLF4 role switching in breast cancer may be associated with the stage and subtype of the disease as it has been implicated in promoting the progression of low-grade primary ductal carcinoma (104) while suppressing highly aggressive triple-negative breast cancer (TNBC). The gene discussed is KLF4; the disease is breast carcinoma.